SkinBioTherapeutics (SBTX) Income Statement

Last quarter (Q2 2023), SkinBioTherapeutics's total revenue was £106.58K, an increase of 385.56% from the same quarter last year. In Q2, SkinBioTherapeutics's net income was £-1.33M. See SkinBioTherapeutics’s key income statements, including revenue, expenses, profit, and income.